key: cord-0703082-w3rol3aq
authors: Ozaras, Resat; Berk, Ahmet; Ucar, Dilek Hasman; Duman, Habibe; Kaya, Fatma; Mutlu, Huseyin
title: Covid‐19 and exacerbation of psoriasis
date: 2020-06-02
journal: Dermatol Ther
DOI: 10.1111/dth.13632
sha: e39dcab1a79b8c95d61aee7538e25b2fda0f3e91
doc_id: 703082
cord_uid: w3rol3aq

nan

We have read the case report of Kutlu and Metin with great interest. 1 They have reported a patient with psoriasis and Covid-19 treated with hydroxychloroquine and oseltamivir. The patient developed exacerbation of psoriasis at fourth day of this treatment. They suggested that the exacerbation of psoriasis was due to the use of hydroxychloroquine, while they briefly discussed the possibility that Covid-19 disease might trigger the exacerbation of psoriasis.

We have recently seen a patient with psoriasis and Covid-19 who may contribute to psoriasis and Covid-19 interaction. 

A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID-19: will cases of psoriasis increase after COVID-19 pandemic?

Risk factors for the development of psoriasis

Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis

Hydroxychloroquine-induced inverse psoriasis

A case of generalized pustular psoriasis caused by hydroxychloroquine in a patient with systemic lupus erythematosus